Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Laura Toccacieli is active.

Publication


Featured researches published by Laura Toccacieli.


Antimicrobial Agents and Chemotherapy | 2008

Increase of Virulence and Its Phenotypic Traits in Drug-Resistant Strains of Candida albicans

Letizia Angiolella; Anna Rita Stringaro; Flavia De Bernardis; Brunella Posteraro; Mariantonietta Bonito; Laura Toccacieli; Antonella Torosantucci; Marisa Colone; Maurizio Sanguinetti; Antonio Cassone; Anna Teresa Palamara

ABSTRACT There is concern about the rise of antifungal drug resistance, but little is known about comparative biological properties and pathogenicity of drug-resistant strains. We generated fluconazole (FLC; CO23RFLC)- or micafungin (FK; CO23RFK)-resistant strains of Candida albicans by treating a FLC- and FK-susceptible strain of this fungus (CO23S) with stepwise-increasing concentrations of either drug. Molecular analyses showed that CO23RFLC had acquired markedly increased expression of the drug-resistance efflux pump encoded by the MDR1 gene, whereas CO23RFK had a homozygous mutation in the FSK1 gene. These genetic modifications did not alter to any extent the growth capacity of the drug-resistant strains in vitro, either at 28°C or at 37°C, but markedly increased their experimental pathogenicity in a systemic mouse infection model, as assessed by the overall mortality and target organ invasion. Interestingly, no apparent increase in the vaginopathic potential of the strains was observed with an estrogen-dependent rat vaginal infection. The increased pathogenicity of drug-resistant strains for systemic infection was associated with a number of biochemical and physiological changes, including (i) marked cellular alterations associated with a different expression and content of major cell wall polysaccharides, (ii) more rapid and extensive hypha formation in both liquid and solid media, and (iii) increased adherence to plastic and a propensity for biofilm formation. Overall, our data demonstrate that experimentally induced resistance to antifungal drugs, irrespective of drug family, can substantially divert C. albicans biology, affecting in particular biological properties of potential relevance for deep-seated candidiasis.


PLOS ONE | 2010

The Reverse Transcription Inhibitor Abacavir Shows Anticancer Activity in Prostate Cancer Cell Lines

Francesca Carlini; Barbara Ridolfi; Agnese Molinari; Chiara Parisi; Giuseppina Bozzuto; Laura Toccacieli; Giuseppe Formisano; Daniela De Orsi; Silvia Paradisi; Olì Maria Victoria Grober; Maria Ravo; Alessandro Weisz; Romano Arcieri; Stefano Vella; Simona Gaudi

Background Transposable Elements (TEs) comprise nearly 45% of the entire genome and are part of sophisticated regulatory network systems that control developmental processes in normal and pathological conditions. The retroviral/retrotransposon gene machinery consists mainly of Long Interspersed Nuclear Elements (LINEs-1) and Human Endogenous Retroviruses (HERVs) that code for their own endogenous reverse transcriptase (RT). Interestingly, RT is typically expressed at high levels in cancer cells. Recent studies report that RT inhibition by non-nucleoside reverse transcriptase inhibitors (NNRTIs) induces growth arrest and cell differentiation in vitro and antagonizes growth of human tumors in animal model. In the present study we analyze the anticancer activity of Abacavir (ABC), a nucleoside reverse transcription inhibitor (NRTI), on PC3 and LNCaP prostate cancer cell lines. Principal Findings ABC significantly reduces cell growth, migration and invasion processes, considerably slows S phase progression, induces senescence and cell death in prostate cancer cells. Consistent with these observations, microarray analysis on PC3 cells shows that ABC induces specific and dose-dependent changes in gene expression, involving multiple cellular pathways. Notably, by quantitative Real-Time PCR we found that LINE-1 ORF1 and ORF2 mRNA levels were significantly up-regulated by ABC treatment. Conclusions Our results demonstrate the potential of ABC as anticancer agent able to induce antiproliferative activity and trigger senescence in prostate cancer cells. Noteworthy, we show that ABC elicits up-regulation of LINE-1 expression, suggesting the involvement of these elements in the observed cellular modifications.


International Journal of Cancer | 2007

m‐THPC‐mediated photodynamic therapy of malignant gliomas: Assessment of a new transfection strategy

Agnese Molinari; Cecilia Bombelli; Stefano Mannino; Annarita Stringaro; Laura Toccacieli; Annarica Calcabrini; Marisa Colone; Annunziato Mangiola; Giulio Maira; Paola Luciani; Giovanna Mancini; Giuseppe Arancia

Malignant gliomas represent the most common primary brain tumor: more than 50% of them are glioblastoma multiforme (GBM). Photodynamic therapy may offer a very good chance of targeted destruction of infiltrating GBM cells, thus increasing the survival time and recurrence‐free interval of GBM patients. Among photosensitizing agents, meta‐tetrahydroxyphenylchlorin (m‐THPC) is promising for the treatment of brain tumors. In previous studies, we investigated the transfection activity of dimyristoyl‐sn‐glycero‐phosphatidylcholine (DMPC) liposomes, containing a cationic gemini surfactant, loaded with m‐THPC on human colon adenocarcinoma and glioblastoma cell lines. In this paper, the uptake and the intracellular distribution of m‐THPC, loaded in several formulations of cationic liposomes, were analyzed, by making a comparison with those obtained using the same chlorin in the pharmaceutical form (Foscan®). Moreover, by cloning efficiency assay the potential therapeutic efficiency of chlorin delivered by liposome formulations was compared with that of the pharmaceutical compound, before and after irradiation with laser light at 652 nm. The obtained results indicated that cationic liposomes (i) transferred m‐THPC in glioblastoma cells more efficiently than pharmaceutical formulation; (ii) significantly (p < 0.001) increased the m‐THPC cytotoxic effect after laser irradiation; (iii) seemed to exert their cytotoxic action in the early phase of interaction with the cells, during adhesion to the plasma membrane.


Journal of Cellular Biochemistry | 2011

Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells

Paolo Grieco; Renato Franco; Giuseppina Bozzuto; Laura Toccacieli; Alessandro Sgambato; Monica Marra; Silvia Zappavigna; Mario Migaldi; Giulio Rossi; Stefano Striano; Luigi Marra; Luigi Gallo; Achille Cittadini; Gerardo Botti; Ettore Novellino; Agnese Molinari; Alfredo Budillon; Michele Caraglia

Urotensin II (UT‐II) is a potent vasoconstrictor peptide and its receptor (UTR) was correlated with human cortico‐adrenal carcinoma proliferation. In this study, we have evaluated the correlation between UTR expression and prognosis of human prostate adenocarcinoma and the involvement of this receptor in the regulation of biological properties on both in vivo and in vitro models. UTR mRNA and protein, evaluated by real‐time PCR and Western blotting, respectively, were expressed at high levels only in androgen‐dependent LNCaP cells. In order to investigate UTR changes occurring in human prostate tumorigenesis, we have also evaluated the expression of UTR in vivo in 195 human prostate tissue samples. UTR was always expressed at low intensity in hyperplastic tissues and at high intensity in well‐differentiated carcinomas (Gleason 2–3). Moreover, we have evaluated the effects of an antagonist of UTR, urantide on migration and invasion of LNCaP cells. Urantide induced a dose‐dependent decrease of motility and invasion of LNCaP cells whose characteristic ameboid movement seems to be advantageous for their malignancy. These effects were paralleled by down‐regulating the autophosphorylation of focal adhesion kinase and the integrin surface expression on LNCaP cells. The effects on cell motility and invasion were likely due to the inhibition of RhoA activity induced by both urantide and shRNA UTR. These data suggest that UTR can be considered a prognostic marker in human prostate adenocarcinoma patients. J. Cell. Biochem. 112: 341–353, 2011.


Planta Medica | 2011

Tea tree oil might combat melanoma.

Giuseppina Bozzuto; Marisa Colone; Laura Toccacieli; Annarita Stringaro; Agnese Molinari

In this study we present new data from experiments focused on the antitumor activity of tea tree oil (TTO), an essential oil distilled from Melaleuca alternifolia. TTO proved to be capable of inhibiting the growth of melanoma cells and of overcoming multidrug resistance (MDR), as we reported in our previous study. Moreover, the survival role of the MDR-marker P-glycoprotein appears to be involved in the mechanism of invasion of melanoma cells. The results reported herein indicate that TTO and its main active component, terpinen-4-ol, can also interfere with the migration and invasion processes of drug-sensitive and drug-resistant melanoma cells.


Journal of Chemotherapy | 2013

Characterization of biofilms in drug-sensitive and drug-resistant strains of Candida albicans

Elisabetta Vavala; Marisa Colone; Claudio Passariello; Ignacio Celestino; Laura Toccacieli; Annarita Stringaro; Letizia Angiolella

Abstract In this study, we investigated the biofilm formation in strains of Candida albicans susceptible (CO23) or resistant to fluconazole (CO23RFLC) or micafungin (CO23RFK). The effect of drug resistance on biofilm formation was investigated through the cell surface hydrophobicity and the mannan content. Moreover, biofilm formation was evaluated after 24, 48 and 72 hours with crystal violet assay, dry weight, as well as scanning electron microscopy. Our results showed an increase in hydrophobicity, polysaccharides content, metabolic activity and dry weight. Observation of sensitive and resistant strains confirmed the differences in cell morphology. Finally, the expression of genes involved in biofilm formation, such as HWP1 and EFG1, evaluated with relative real-time RT-PCR. Resistant strains proved to up- regulate the expression of HWP1. These results demonstrated the existence of important differences between drug-susceptible and drug-resistant strains biofilm of C. albicans.


Journal of Investigative Dermatology | 2004

Terpinen-4-ol, The Main Component of Melaleuca Alternifolia (Tea Tree) Oil Inhibits the In Vitro Growth of Human Melanoma Cells

Annarica Calcabrini; Annarita Stringaro; Laura Toccacieli; Stefania Meschini; Manuela Marra; Marisa Colone; Giuseppe Arancia; Agnese Molinari; Giuseppe Salvatore; Francesca Mondello


Journal of Investigative Dermatology | 2008

The Multidrug Transporter P-Glycoprotein: A Mediator of Melanoma Invasion?

Marisa Colone; Annarica Calcabrini; Laura Toccacieli; Giuseppina Bozzuto; Annarita Stringaro; Massimo Gentile; Maurizio Cianfriglia; Alessandra Ciervo; Michele Caraglia; Alfredo Budillon; Giuseppina Meo; Giuseppe Arancia; Agnese Molinari


Journal of Medicinal Chemistry | 2005

Inclusion of a photosensitizer in liposomes formed by DMPC/gemini surfactant: correlation between physicochemical and biological features of the complexes.

Cecilia Bombelli; Giulio Caracciolo; Pietro Di Profio; Marco Diociaiuti; Paola Luciani; Giovanna Mancini; Claudia Mazzuca; Manuela Marra; Agnese Molinari; Donato Monti; Laura Toccacieli; Mariano Venanzi


Journal of Medicinal Chemistry | 2006

Interaction of Tea Tree Oil with Model and Cellular Membranes

Cristiano Giordani; Agnese Molinari; Laura Toccacieli; Annarica Calcabrini; Annarita Stringaro; Pietro Chistolini; Giuseppe Arancia; Marco Diociaiuti

Collaboration


Dive into the Laura Toccacieli's collaboration.

Top Co-Authors

Avatar

Agnese Molinari

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Annarita Stringaro

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Marisa Colone

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Annarica Calcabrini

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Giuseppe Arancia

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Giuseppina Bozzuto

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Cecilia Bombelli

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Giovanna Mancini

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Annunziato Mangiola

The Catholic University of America

View shared research outputs
Top Co-Authors

Avatar

Paola Luciani

Sapienza University of Rome

View shared research outputs
Researchain Logo
Decentralizing Knowledge